Skip to content
Jackson Walker
  • People

        • View All People
  • Experience
        • Bankruptcy, Restructuring, & Recovery
        • Business Immigration & Compliance
        • Corporate & Securities
        • Cybersecurity, Data Protection, & Privacy
        • Employee Benefits & Executive Compensation (ERISA)
        • Energy
        • Environment & Natural Resources
        • Finance & Banking
        • Government Relations & Public Policy
        • Healthcare
        • Intellectual Property
        • International
        • Investigations & White Collar Defense
        • Labor & Employment
        • Land Use
        • Real Estate
        • Tax
        • Trial & Appellate Litigation
        • Trusts & Estates
  • News
        • All News
        • Fast Takes Podcasts
        • Future-Ready Business Podcast
        • Insights
        • Subscribe to JW News & Insights
  • Offices
        • Austin
        • Dallas
        • Fort Worth
        • Houston
        • San Angelo
        • San Antonio
  • Meet JW
    • How We Work
      • Globalaw
      • Project Management
      • Value Management
    • What We Value
      • Community
      • Diversity & Inclusion
      • Jackson Walker Women
      • Pro Bono
    • Who We Are
      • Meet JW Videos
      • Fast Takes Podcasts
      • Recognition
      • JW Alumni
  • JW Careers
  • Contact Us
  • Search



Contact | Careers
Jackson Walker
David B. Deaton

David B. Deaton

Partner, Houston
713.752.4508
ddeaton@jw.com
Email LinkedIn vCard Print
Recognition & Accolades Community Involvement Client Results Attorney News

Practice Areas

  • Corporate & Securities

Experience

  • Acquisition & Disposition | Energy
  • Capital Markets
  • Corporate Governance
  • Investment Funds
  • Mergers, Acquisitions, & Divestitures

Biography

David Deaton is a partner in the Corporate & Securities group at Jackson Walker. His primary focus is representing developers and equity sources in connection with structuring and drafting real estate joint ventures for the development and acquisition of multifamily, office and industrial projects. David provides what clients want most: expert advice on joint venture strategy, increased deal certainty, risk management, and the ability to realize the strategic and economic benefits of the joint venture.

David also represents private and public companies in connection with private placements of securities, corporate restructurings, mergers, acquisitions and divestitures and general corporate matters.

Education

B.A., University of Texas at Austin

M.S.C.J., Southwest Texas State University

J.D., magna cum laude, South Texas College of Law Houston

Bar Admissions

Texas

Recognition & Accolades Community Involvement Client Results Attorney News
  • Super Lawyers – Rising Stars, Thomson Reuters, 2005-2009
  • Houston’s Top Lawyers, H Texas magazine, 2010
  • Houston Professionals on the Fast Track, H Texas magazine, 2007, 2009
  • State Bar of Texas
  • Houston Bar Association – Corporate Section
‘Austin Business Journal’ Names Mixed-Use Development Financed by Jackson Walker Client Lionstone Investments the “Project of the Year” for 2020

September 24, 2020

Jackson Walker Represents Buyer in Largest U.S. Ranch Sale of 2017

August 22, 2017

Jackson Walker Represents Pernix Therapeutics in $25 Million Acquisition Deal

January 14, 2013

More Client Results

City of Austin, Texas with Jackson Walker logo

September 24, 2020

Client Results

‘Austin Business Journal’ Names Mixed-Use Development Financed by Jackson Walker Client Lionstone Investments the “Project of the Year” for 2020

Transformed from a 10-acre former rail yard to a mixed-use urban district with 800 apartment units and 115,000 square feet of retail over a three-year period, the Saltillo District has quickly developed into a new hub in Central Texas with one of the region’s most diverse mobility infrastructure programs.

August 22, 2017

Client Results

Jackson Walker Represents Buyer in Largest U.S. Ranch Sale of 2017

Jackson Walker’s real estate group has successfully represented the buyer of Cielo Vista Ranch, an 83,000-acre stretch of land in Southern Colorado.

January 14, 2013

Client Results

Jackson Walker Represents Pernix Therapeutics in $25 Million Acquisition Deal

Jackson Walker is representing Pernix Therapeutics Holdings, Inc. in its deal to acquire Somaxon Pharmaceuticals, Inc.

More Attorney News

Recognition & Accolades

  • Super Lawyers – Rising Stars, Thomson Reuters, 2005-2009
  • Houston’s Top Lawyers, H Texas magazine, 2010
  • Houston Professionals on the Fast Track, H Texas magazine, 2007, 2009

Community Involvement

  • State Bar of Texas
  • Houston Bar Association – Corporate Section

Practice Areas

  • Corporate & Securities

Experience

  • Acquisition & Disposition | Energy
  • Capital Markets
  • Corporate Governance
  • Investment Funds
  • Mergers, Acquisitions, & Divestitures
© 2023 Jackson Walker LLP
  • Terms of Use
  • Cookies & Tracking Policy
  • Privacy Policy
  • Attorney Advertising
  • SCAC
  • JW Login
LinkedIn Twitter Facebook Instagram
  • Who We Are
  • What We Value
  • How We Work
Subscribe to JW News & Insights
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. View Cookie Policy Allow Cookies
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT